Bridges Investment Management Inc. Sells 77 Shares of Danaher Co. (NYSE:DHR)

Bridges Investment Management Inc. cut its position in shares of Danaher Co. (NYSE:DHR) by 8.0% during the third quarter, HoldingsChannel.com reports. The firm owned 884 shares of the conglomerate’s stock after selling 77 shares during the period. Bridges Investment Management Inc.’s holdings in Danaher were worth $246,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of DHR. Klingman & Associates LLC increased its holdings in Danaher by 11.7% in the 3rd quarter. Klingman & Associates LLC now owns 2,017 shares of the conglomerate’s stock valued at $561,000 after buying an additional 211 shares during the period. Assetmark Inc. increased its stake in Danaher by 6.2% in the third quarter. Assetmark Inc. now owns 67,234 shares of the conglomerate’s stock valued at $18,692,000 after acquiring an additional 3,948 shares during the period. First Fiduciary Investment Counsel Inc. lifted its stake in Danaher by 2.2% during the third quarter. First Fiduciary Investment Counsel Inc. now owns 42,055 shares of the conglomerate’s stock worth $11,692,000 after purchasing an additional 914 shares during the period. SpiderRock Advisors LLC boosted its holdings in Danaher by 26.5% during the third quarter. SpiderRock Advisors LLC now owns 17,862 shares of the conglomerate’s stock valued at $4,966,000 after purchasing an additional 3,742 shares in the last quarter. Finally, CWA Asset Management Group LLC bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $978,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Royal Bank of Canada decreased their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Wells Fargo & Company assumed coverage on shares of Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price on the stock. UBS Group decreased their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Stephens restated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Finally, Raymond James reduced their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Stock Performance

Shares of DHR stock opened at $245.39 on Friday. The company has a market capitalization of $177.24 billion, a P/E ratio of 46.83, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. Danaher Co. has a 52 week low of $192.35 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company’s 50 day moving average price is $264.89 and its two-hundred day moving average price is $260.71.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.02 EPS. On average, analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.